ClassID:

95301

C07D417/12 - page 6 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#1501
20200002324
2020-01-02

Dual mechanism inhibitors for the treatment of disease

#1502
20200002310
2020-01-02

SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH

#1503
20200002283
2020-01-02

PYRAZOLE DERIVATIVES HAVING ACTIVITY AGAINST PAIN

#1504
20200002279
2020-01-02

Inhibitors of EGFR and methods of use thereof

#1505
20200000802
2020-01-02

Phthalazinone derivatives

#1506
20200000788
2020-01-02

5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same

#1507
20200000777
2020-01-02

Isoxazoline-substituted benzamide compound and pesticide

#1508
20190390172
2019-12-26

Agent for removing undifferentiated iPS cells

#1509
20190389852
2019-12-26

Process for preparing 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-thiazolidinedione and salts thereof

#1510
20190389815
2019-12-26

Benzylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof

#1511
20190389803
2019-12-26

Antiviral drug for severe fever with thrombocytopenia syndrome

#1512
20190388415
2019-12-26

Substituted dihydrobenzofuran glycosidase inhibitors

#1513
20190382407
2019-12-19

3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives

#1514
20190382398
2019-12-19

Benzenesulfonamide compounds and their use as therapeutic agents

#1515
20190382386
2019-12-19

Inhibitors of mechanotransduction to treat pain and modulate touch perception

#1516
20190382385
2019-12-19

Tetrazolinone compounds and its use as pest control agents

#1517
20190382358
2019-12-19

HETEROCYCLIC COMPOUNDS AS PESTICIDES

#1518
20190381010
2019-12-19

Pyrazole derivatives as bromodomain inhibitors

#1519
20190375744
2019-12-12

Thiazole derivative and applications thereof

#1520
20190375743
2019-12-12

Compounds and methods for modulating interleukin-2-inducible t-cell kinase

#1521
20190375708
2019-12-12

Hepatitis B capsid assembly modulators

#1522
20190367533
2019-12-05

Glycosidase inhibitors

#1523
20190367501
2019-12-05

Prodrugs of Nh-acidic compounds

#1524
20190367500
2019-12-05

Quinazoline derivative

#1525
20190367499
2019-12-05

Compounds for pain treatment, compositions comprising same, and methods of using same

#1526
20190367460
2019-12-05

Heterocyclic compounds as pesticides

#1527
20190367459
2019-12-05

Heterocyclic compounds as pesticides

#1528
20190367452
2019-12-05

MASP-2 inhibitors and methods of use

#1529
20190365768
2019-12-05

N-{[2-(piperidin-1-yl)phenyl](phenyl)methyl}-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)acetamide derivatives and related compounds as ROR-gamma modulators for treating autoimmune diseases

#1530
20190365721
2019-12-05

Amine prodrugs of pharmaceutical compounds

#1531
20190359620
2019-11-28

Heteroaryl SYK inhibitors

#1532
20190359578
2019-11-28

TRIAZOLE BENZAMIDE DERIVATIVES AND THE COMPOSITIONS AND METHODS OF TREATMENT REGARDING THE SAME

#1533
20190359564
2019-11-28

Sulfonylureas and related compounds and use of same

#1534
20190358669
2019-11-28

Display inserts, overlays, and graphical user interfaces for multimedia systems

#1535
20190358228
2019-11-28

2,4-pyrimidinediamine compounds and their uses

#1536
20190352600
2019-11-21

Methods of enhancing cell survival of stem cells

#1537
20190352298
2019-11-21

Aminothiazole compounds as c-Kit inhibitors

#1538
20190352296
2019-11-21

Oxazole derivatives for use in the treatment of cancer

#1539
20190352275
2019-11-21

Thiophene derivatives as antiviral agents

#1540
20190352271
2019-11-21

MCL-1 inhibitors

#1541
20190352267
2019-11-21

Compounds, compositions and methods

#1542
20190352266
2019-11-21

Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof

#1543
20190352256
2019-11-21

Compounds useful for treating a or infection

#1544
20190345151
2019-11-14

Ferroportin inhibitors

#1545
20190345145
2019-11-14

Sulphamoylaryl derivatives and use thereof as medicaments for the treatment of liver fibrosis

#1546
20190345119
2019-11-14

SHMT inhibitors and uses thereof

#1547
20190345109
2019-11-14

Therapeutic compounds and compositions

#1548
20190345104
2019-11-14

Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides

#1549
20190343797
2019-11-14

Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

#1550
20190330621
2019-10-31

Specific synthetic chimeric xenonucleic acid guide RNA; s(XNA-gRNA) for enhancing CRISPR mediated genome editing efficiency

#1551
20190330239
2019-10-31

Indazole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2

#1552
20190330238
2019-10-31

Bisaryl amides as NRF2 activators

#1553
20190330202
2019-10-31

Compounds

#1554
20190330169
2019-10-31

Substituted piperazines as selective HDAC1,2 inhibitors

#1555
20190330168
2019-10-31

Microbiocidal thiazole derivatives

#1556
20190330167
2019-10-31

ACTIVATORS OF HIV LATENCY

#1557
20190330160
2019-10-31

Heterocyclic substituted 2-amino quinazoline derivatives for the treatment of viral infections

#1558
20190322659
2019-10-24

Inhibitors of lysine gingipain

#1559
20190322652
2019-10-24

Modulators of indoleamine 2,3-dioxygenase

#1560
20190322628
2019-10-24

HIV replication inhibiting pyrimidines

#1561
20190322626
2019-10-24

Human plasma kallikrein inhibitors

#1562
20190322624
2019-10-24

1-cyano-pyrrolidine compounds as USP30 inhibitors

#1563
20190315735
2019-10-17

Cyclopropanamine compound and use thereof

#1564
20190315731
2019-10-17

6-(BUTA-1,3-DIYN-1-YL)BENZO[D]THIAZOLE DERIVATIVES

#1565
20190308965
2019-10-10

Heteroaryl amides as inhibitors of protein aggregation

#1566
20190308960
2019-10-10

Compounds, compositions, and methods for increasing CFTR activity

#1567
20190308955
2019-10-10

2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds

#1568
20190308942
2019-10-10

Small molecule inducers of reactive oxygen species and inhibitors of mitochondrial activity

#1569
20190300513
2019-10-03

Sting agonist compounds

#1570
20190300496
2019-10-03

Benzo-N-hydroxy amide compounds having antitumor activity

#1571
20190298705
2019-10-03

Chemical Compounds

#1572
20190292177
2019-09-26

Process for the preparation of dasatinib polymorph

#1573
20190292173
2019-09-26

Compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or benzo[d][1,3]oxathiole 3,3-dioxide and methods/uses thereof as agonists of g protein-coupled receptor 119

#1574
20190292160
2019-09-26

Substituted N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase

#1575
20190290778
2019-09-26

Methods and compounds for targeted autophagy

#1576
20190290654
2019-09-26

Substituted quinoxaline DNA-PK inhibitors

#1577
20190284224
2019-09-19

Cyclic peroxides as prodrugs for selective delivery of agents

#1578
20190284207
2019-09-19

NOVEL ULK1 INHIBITORS AND METHODS USING SAME

#1579
20190284181
2019-09-19

PRODRUGS OF NH-ACIDIC COMPOUNDS

#1580
20190284173
2019-09-19

Triazole phenyl compounds as agonists of the APJ receptor

#1581
20190284138
2019-09-19

1-cyano-pyrrolidine compounds as USP30 inhibitors

#1582
20190284135
2019-09-19

PRIMARY CARBOXAMIDES AS BTK INHIBITORS

#1583
20190282548
2019-09-19

Triazolone compounds as mPGES-1 inhibitors

#1584
20190276460
2019-09-12

Crystalline form of (1R,2R)-2-[4-(3-methyl-1H-pyrazol-5-yl)benzoyl]-N-(4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazin-3-yl)cyclohexanecarboxamide

#1585
20190276447
2019-09-12

Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease

#1586
20190276406
2019-09-12

Heterocyclic compounds for the treatment of neurological and psychological disorders

#1587
20190276395
2019-09-12

4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase

#1588
20190270751
2019-09-05

Bicyclic-fused heteroaryl or aryl compounds

#1589
20190270732
2019-09-05

1-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof

#1590
20190270713
2019-09-05

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

#1591
20190270708
2019-09-05

1-cyano-pyrrolidine compounds as USP30 inhibitors

#1592
20190270705
2019-09-05

Fine-tune modulators of neuronal excitability for neuropsychiatric disorders

#1593
20190269683
2019-09-05

Modulators of cystic fibrosis transmembrane conductance regulator

#1594
20190269669
2019-09-05

4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS

#1595
20190269665
2019-09-05

Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone

#1596
20190269650
2019-09-05

Somatostatin receptor subtype 4 (SSTR4) agonists

#1597
20190263798
2019-08-29

NOVEL COMPOUNDS

#1598
20190263775
2019-08-29

Glucosylceramide synthase inhibitors for the treatment of diseases

#1599
20190263758
2019-08-29

ACSS2 inhibitors and methods of use thereof

#1600
20190263757
2019-08-29

3-phenyl-pyrazole derivatives as modulators of the 5-HTserotonin receptor useful for the treatment of disorders related thereto

#1601
20190263754
2019-08-29

Antiviral compounds

#1602
20190262356
2019-08-29

Heterocyclic amides as kinase inhibitors

#1603
20190256508
2019-08-22

Compounds as ROR gamma modulators

#1604
20190256504
2019-08-22

Cardiac sarcomere inhibitors

#1605
20190256476
2019-08-22

Compositions and methods for inhibition of the JAK pathway

#1606
20190255067
2019-08-22

Hepatitis B core protein modulators

#1607
20190255066
2019-08-22

Fluorohydroxyproline derivatives useful in the preparation of proteolysis targeted chimeras

#1608
20190255062
2019-08-22

DNA-PK inhibitors

#1609
20190255047
2019-08-22

2,4-pyrimidinediamine compounds and their uses

#1610
20190255032
2019-08-22

2,4-Thiazolidinedione Derivatives in the Treatment of Central Nervous System Disorders

#1611
20190248806
2019-08-15

ULK1 inhibitors and methods using same

#1612
20190248752
2019-08-15

Heterocyclic containing cyclopropyl FXR modulators

#1613
20190241588
2019-08-08

Tricyclic sulfones as RORγ modulators

#1614
20190241578
2019-08-08

NOVEL COMPOSITIONS USEFUL IN TREATING BRAIN-RELATED DISEASES OR DISORDERS AND METHODS USING SAME

#1615
20190241554
2019-08-08

1,3 di-substituted cyclobutane or azetidine derivatives as hematopoietic prostaglandin D synthase inhibitors

#1616
20190241533
2019-08-08

Compounds and compositions for inhibition of FASN

#1617
20190241532
2019-08-08

Compounds and compositions for inhibition of FASN

#1618
20190241526
2019-08-08

Hsp70 modulators and methods for making and using the same

#1619
20190241523
2019-08-08

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

#1620
20190241521
2019-08-08

Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof

#1621
20190241514
2019-08-08

Elimination of hepatitis B virus with antiviral agents

#1622
20190241506
2019-08-08

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

#1623
20190240232
2019-08-08

Selective bromodomain inhibition of fungal Bdf1

#1624
20190233471
2019-08-01

Cytotoxic tubulysin compounds for conjugation

#1625
20190233406
2019-08-01

HYDROXYALKYLAMINE- and HYDROXYCYCLOALKYLAMINE-SUBSTITUTED DIAMINE-ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS

#1626
20190233384
2019-08-01

Anti-infective heterocyclic compounds and uses thereof

#1627
20190233376
2019-08-01

Guanidine derivative and medical use thereof

#1628
20190231799
2019-08-01

COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES

#1629
20190225602
2019-07-25

Propionic acid derivatives and methods of use thereof

#1630
20190225593
2019-07-25

Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same

#1631
20190225575
2019-07-25

Antiviral compounds

#1632
20190218208
2019-07-18

Bicyclic compounds useful as GPR120 modulators

#1633
20190218204
2019-07-18

Biaryl inhibitors of Bruton'S tyrosine kinase

#1634
20190216810
2019-07-18

Small molecule regulators of steroid receptor coactivators and methods of use thereof

#1635
20190216808
2019-07-18

Hepatitis B antiviral agents

#1636
20190216774
2019-07-18

TRPV4 antagonists

#1637
20190211006
2019-07-11

Aztreonam derivatives and uses thereof

#1638
20190210986
2019-07-11

CYCLIC PROTEIN TYROSINE KINASE INHIBITORS

#1639
20190210985
2019-07-11

Modulators of indoleamine 2,3-dioxygenase and methods of using the same

#1640
20190209550
2019-07-11

Azadecalin derivatives as inhibitors of human immunodeficiency virus replication

#1641
20190209548
2019-07-11

LINKED DIARYL COMPOUNDS WITH ANTICANCER PROPERTIES AND METHODS OF USING THE SAME

#1642
20190209536
2019-07-11

COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR

#1643
20190202811
2019-07-04

Aminoacylindazole immunomodulators for treatment of autoimmune diseases

#1644
20190202790
2019-07-04

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

#1645
20190201413
2019-07-04

Heterocyclic amides as kinase inhibitors

#1646
20190194184
2019-06-27

Benzenesulfonamide compounds and their use as therapeutic agents

#1647
20190194182
2019-06-27

RAD51 inhibitors

#1648
20190194181
2019-06-27

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

#1649
20190194179
2019-06-27

ANTIBIOTIC COMPOUNDS

#1650
20190194173
2019-06-27

6-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1H)-one as APJ agonists

#1651
20190194166
2019-06-27

Substituted pyridines as inhibitors of DNMT1

#1652
20190194165
2019-06-27

Spiro three-membered ring, spiro five-membered ring peptide deformylase inhibitor and use thereof in antibacteria and anti-tumor

#1653
20190194145
2019-06-27

Amino quinazolines as kinase inhibitors

#1654
20190192699
2019-06-27

NUCLEAR IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING CARBONIC ANHYDRASE IX AND USES THEREOF

#1655
20190192526
2019-06-27

ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS

#1656
20190185498
2019-06-20

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

#1657
20190185466
2019-06-20

1,3-thiazol-2-yl substituted benzamides

#1658
20190185464
2019-06-20

Oxopicolinamide derivative, preparation method therefor and pharmaceutical use thereof

#1659
20190185462
2019-06-20

3-aryl- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histonedeacetylase 6 (HDAC6) inhibitors

#1660
20190185450
2019-06-20

1,3-dihydroxy-phenyl derivatives useful as immunomodulators

#1661
20190177278
2019-06-13

4-substituted aminoisoquinoline derivatives

#1662
20190175606
2019-06-13

Biaryl amide compounds as kinase inhibitors

#1663
20190175567
2019-06-13

Compounds and methods for kinase modulation, and indications therefor

#1664
20190167651
2019-06-06

Heteroaryl sulfonamides and CCR2/CCR9

#1665
20190167648
2019-06-06

Glutaminase inhibitors

#1666
20190167636
2019-06-06

METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C

#1667
20190166842
2019-06-06

Insecticidal compounds based on isoxazoline derivatives

#1668
20190161481
2019-05-30

(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

#1669
20190161461
2019-05-30

RIBONUCLEOTIDE REDUCTASE INHIBITORS AND METHODS OF USE

#1670
20190161448
2019-05-30

SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS USEFUL AS GPR120 AGONISTS

#1671
20190161447
2019-05-30

Indole derivatives and their use in neurodegenerative diseases

#1672
20190161445
2019-05-30

Urea derivative or pharmacologically acceptable salt thereof

#1673
20190160046
2019-05-30

Modulators of calcium release-activated calcium channel

#1674
20190153010
2019-05-23

Antibacterial sideromycins

#1675
20190152991
2019-05-23

PRO-DRUGS OF NSAIAS WITH VERY HIGH SKIN AND MEMBRANES PENETRATION RATES AND THEIR NEW MEDICINAL USES

#1676
20190152989
2019-05-23

ULK1 inhibitors and methods using same

#1677
20190152988
2019-05-23

ISOINDOLINE, AZAISOINDOLINE, DIHYDROINDENONE AND DIHYDROAZAINDENONE INHIBITORS OF MNK1 AND MNK2

#1678
20190152967
2019-05-23

PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA SELECTIVE AGONISTS FOR INHIBITION OF RETINAL PIGMENT EPITHELIUM DEGENERATION OR GEOGRAPHIC ATROPHY

#1679
20190152966
2019-05-23

Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer

#1680
20190152943
2019-05-23

Tetrahydroindazoles and medical uses thereof

#1681
20190152938
2019-05-23

Compounds for treating parasitic infections

#1682
20190152913
2019-05-23

1,4-substituted piperidine derivatives

#1683
20190151306
2019-05-23

MDR-reversing 8-hydroxy-quinoline derivatives

#1684
20190151298
2019-05-23

Methods and drug products for treating Alzheimer's disease

#1685
20190144473
2019-05-16

Amino compounds for treatment of complement mediated disorders

#1686
20190144467
2019-05-16

Anti-fibrotic pyridinones

#1687
20190144450
2019-05-16

Modulators of ATP-binding cassette transporters

#1688
20190144426
2019-05-16

Quinazolines as potassium ion channel inhibitors

#1689
20190144382
2019-05-16

MEK Inhibitors and Methods of Their Use

#1690
20190142043
2019-05-16

Sweetness and taste improvement of steviol glycoside or mogroside sweeteners

#1691
20190135825
2019-05-09

Quinazoline and indole compounds to treat medical disorders

#1692
20190135821
2019-05-09

Small molecules active against gram-negative bacteria

#1693
20190135791
2019-05-09

Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators

#1694
20190135770
2019-05-09

Heterocyclic derivatives for the treatment of RSV

#1695
20190135768
2019-05-09

Aryl dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease

#1696
20190135752
2019-05-09

SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS

#1697
20190135746
2019-05-09

Indoline derivatives and method for using and producing the same

#1698
20190135718
2019-05-09

SMALL MOLECULE INHIBITORS OF NECROPTOSIS

#1699
20190133128
2019-05-09

Fungicidal pyridazinones

#1700
20190127362
2019-05-02

Spirocyclic compounds as farnesoid X receptor modulators

#1701
20190127361
2019-05-02

Aryl and heteroaryl amides for use as anti-proliferative, anti-thrombotic, and anti-viral agents

#1702
20190127360
2019-05-02

Compounds for modulating aquaporins

#1703
20190127359
2019-05-02

Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin Ligase

#1704
20190127358
2019-05-02

Bridged bicyclic compounds as farnesoid X receptor modulators

#1705
20190127346
2019-05-02

Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds

#1706
20190119301
2019-04-25

Thiazolyl-containing compounds for treating proliferative diseases

#1707
20190119295
2019-04-25

COMPOSITIONS AND METHODS FOR TREATING CANCER

#1708
20190119224
2019-04-25

Compounds and compositions for treating conditions associated with NLRP activity

#1709
20190119223
2019-04-25

Modulators of indoleamine 2,3-dioxygenase

#1710
20190119219
2019-04-25

PKM2 modulators and methods for their use

#1711
20190119217
2019-04-25

Tyrosine kinase inhibitor and pharmaceutical composition comprising same

#1712
20190119203
2019-04-25

Compounds and compositions for treating conditions associated with NLRP activity

#1713
20190112318
2019-04-18

Compounds, compositions and methods

#1714
20190112303
2019-04-18

Pesticidally active amide heterocyclic derivatives with sulphur containing substituents

#1715
20190112297
2019-04-18

N-[(Pyrimidinylamino)propanyl]-and N-[(Pyridinylamino)-propanyl]arylcarboxamides

#1716
20190112291
2019-04-18

N-[(pyridyloxy)propanyl]benzamides

#1717
20190112290
2019-04-18

Substituted carboxamides as inhibitors of WDR5 protein-protein binding

#1718
20190110476
2019-04-18

NOVEL ISOTHIAZOLAMIDES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES

#1719
20190106430
2019-04-11

3-(CARBOXYMETHYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES

#1720
20190106413
2019-04-11

Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor I

#1721
20190100536
2019-04-04

Androgen receptor modulating compounds

#1722
20190100517
2019-04-04

COMPOUNDS

#1723
20190100516
2019-04-04

Aztreonam derivatives and uses thereof

#1724
20190100507
2019-04-04

Fluorinated cyclopropylamine compound, preparation method therefor, pharmaceutical composition thereof, and uses thereof

#1725
20190092765
2019-03-28

N-CYCLOALKYL-N-[(HETEROCYCLYLPHENYL)METHYLENE]-(THIO)CARBOXAMIDE DERIVATIVES

#1726
20190092749
2019-03-28

EPAC1 activators as HIV latency reversal agents (LRA)

#1727
20190092743
2019-03-28

Photoelectric conversion element, two-dimensional sensor, image sensor, and image pickup device

#1728
20190092742
2019-03-28

Inhibitors of hepatitis B virus targeting capsid assembly

#1729
20190092735
2019-03-28

Benzimidazolone and benzothiazolone compounds and their use as AMPA receptor modulators

#1730
20190090486
2019-03-28

Microbiocidal oxadiazole derivatives

#1731
20190085005
2019-03-21

Phosphonate compounds for treatment of complement mediated disorders

#1732
20190084991
2019-03-21

Pyrazole derivatives useful as 5-lipdxygenase activating protein (FLAP) inhibitors

#1733
20190084975
2019-03-21

Substituted pyrimidines as LRKK2 inhibitors

#1734
20190084972
2019-03-21

Pyrimidinyloxy benzene derivatives as herbicides

#1735
20190084959
2019-03-21

Pyridinylmethyl carbamimidoylcarbamate derivatives and their use as AOC3 inhibitors

#1736
20190084949
2019-03-21

NEW CLASS OF MU-OPIOID RECEPTOR AGONISTS

#1737
20190084937
2019-03-21

Heterocyclic compounds for the treatment of neurological and psychological disorders

#1738
20190084933
2019-03-21

Indole derivatives for use in medicine

#1739
20190083467
2019-03-21

Aromatic ring compound

#1740
20190077799
2019-03-14

RAD51 inhibitors

#1741
20190077768
2019-03-14

Administration of aurora kinase inhibitors for anti-malarial therapy

#1742
20190077767
2019-03-14

Voltage-dependent t-type calcium channel blocker

#1743
20190077764
2019-03-14

Benzazepine dicarboxamide compounds with secondary amide function

#1744
20190076405
2019-03-14

COMPOUNDS, COMPOSITIONS, AND METHODS FOR PREVENTING METASASIS OF CANCER CELLS

#1745
20190071437
2019-03-07

Protein kinase inhibitors

#1746
20190071435
2019-03-07

GPR120 agonists for the treatment of type II diabetes

#1747
20190071424
2019-03-07

Wnt signaling pathway inhibitors for treatments of disease

#1748
20190071407
2019-03-07

ISOXAZOLINE DERIVATIVES AS INSECTICIDES

#1749
20190070149
2019-03-07

PRIMARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

#1750
20190070146
2019-03-07

Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

#1751
20190062352
2019-02-28

Substituted asymmetric ureas as modulators of ghrelin receptor activity

#1752
20190062333
2019-02-28

CXCR4 receptor antagonists

#1753
20190062324
2019-02-28

Autotaxin inhibitors

#1754
20190062323
2019-02-28

PI-kinase inhibitors with anti-infective activity

#1755
20190062317
2019-02-28

Compounds

#1756
20190062290
2019-02-28

2,3-epoxy succinyl derivative, preparation method and use thereof

#1757
20190062289
2019-02-28

Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound

#1758
20190062276
2019-02-28

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#1759
20190062274
2019-02-28

Heterocyclic compound

#1760
20190060472
2019-02-28

TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS

#1761
20190060282
2019-02-28

Imidazolylamide derivative

#1762
20190059377
2019-02-28

Fungicidal pyrazoles

#1763
20190055239
2019-02-21

Glycosidase inhibitors

#1764
20190055233
2019-02-21

Acid addition salts of piperazine derivatives

#1765
20190055232
2019-02-21

Compounds

#1766
20190055218
2019-02-21

AHR inhibitors and uses thereof

#1767
20190055217
2019-02-21

PIPERIDINYLALKYLAMIDE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN

#1768
20190054068
2019-02-21

Indole Amide Derivatives and Related Compounds for Use in the Treatment of Neurodegenerative Diseases

#1769
20190048033
2019-02-14

Ether compounds for treatment of complement mediated disorders

#1770
20190047995
2019-02-14

Substituted pyrazin-2-amines as inhibitors of ATR kinase

#1771
20190047979
2019-02-14

Sulfonyl amide derivatives for the treatment of abnormal cell growth

#1772
20190047978
2019-02-14

1,2,4-triazine-4-amine derivatives

#1773
20190047969
2019-02-14

Immunoproteasome inhibitor analogs

#1774
20190047968
2019-02-14

6-ACYL-1,2,4-TRIAZINE-3,5-DIONE DERIVATIVE AND HERBICIDES

#1775
20190047964
2019-02-14

Urea compound, preparation method therefor and medical use thereof

#1776
20190046650
2019-02-14

Cellular signalling inhibitors, their formulations and methods thereof

#1777
20190046540
2019-02-14

Treatments for diabetic neuropathy

#1778
20190040092
2019-02-07

Crystalline forms of ethyl ((S)-((((2R,5R)-5-(6-amino-9H-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)methyl)(phenoxy)phosphoryl(-L-alaninate

#1779
20190040054
2019-02-07

Solid state forms of dasatinib and processes for their preparation

#1780
20190040039
2019-02-07

Piperidine derivative

#1781
20190037848
2019-02-07

Novel isothiazolamides, processes for their preparation and their use as herbicides and/or plant growth regulators

#1782
20190031692
2019-01-31

Compounds for treatment of complement mediated disorders

#1783
20190031658
2019-01-31

Benzamide and nicotinamide compounds and methods of using same

#1784
20190031652
2019-01-31

Method of preparing glucosylceramide synthase inhibitors

#1785
20190031649
2019-01-31

Compounds for treatment of trypanosomes and neurological pathogens and uses thereof

#1786
20190031648
2019-01-31

Prodrugs of NH-acidic compounds

#1787
20190031630
2019-01-31

CFTR REGULATORS AND METHODS OF USE THEREOF

#1788
20190031628
2019-01-31

Aminoazole derivative

#1789
20190031607
2019-01-31

Therapeutic compounds and methods of use thereof

#1790
20190031605
2019-01-31

Tetrahydronaphthalene derivative

#1791
20190030013
2019-01-31

CSF-1R inhibitors for treatment of brain tumors

#1792
20190023729
2019-01-24

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

#1793
20190023670
2019-01-24

HDAC inhibitors and therapeutic methods using the same

#1794
20190016714
2019-01-17

Deoxycytidine kinase binding compounds

#1795
20190016694
2019-01-17

Use of substituted oxadiazoles for combating phytopathogenic fungi

#1796
20190016688
2019-01-17

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

#1797
20190016681
2019-01-17

INHIBITORS OF THE PD-1/PD-L1 PROTEIN/PROTEIN INTERACTION

#1798
20190016680
2019-01-17

MAST-CELL MODULATORS AND USES THEREOF

#1799
20190010149
2019-01-10

SUSTAINED-RELEASE FORMULATION FOR INJECTION

#1800
20190010122
2019-01-10

2-cyanoisoindoline derivatives for treating cancer